HBIO
Income statement / Annual
Last year (2025), Harvard Bioscience Inc.'s total revenue was $86.55 M,
a decrease of 8.06% from the previous year.
In 2025, Harvard Bioscience Inc.'s net income was -$56.70 M.
See Harvard Bioscience Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$86.55 M |
$94.14 M |
$112.25 M |
$113.34 M |
$118.90 M |
$102.10 M |
$116.18 M |
$120.77 M |
$101.88 M |
$104.52 M |
| Cost of Revenue |
$40.67 M
|
$39.37 M
|
$46.18 M
|
$52.52 M
|
$51.25 M
|
$44.06 M
|
$51.85 M
|
$57.59 M
|
$54.29 M
|
$56.11 M
|
| Gross Profit |
$45.88 M
|
$54.77 M
|
$66.07 M
|
$60.82 M
|
$67.65 M
|
$58.04 M
|
$64.32 M
|
$63.18 M
|
$47.60 M
|
$48.42 M
|
| Gross Profit Ratio |
0.53
|
0.58
|
0.59
|
0.54
|
0.57
|
0.57
|
0.55
|
0.52
|
0.47
|
0.46
|
| Research and Development Expenses |
$8.83 M
|
$10.41 M
|
$11.76 M
|
$12.33 M
|
$10.80 M
|
$8.69 M
|
$10.72 M
|
$10.99 M
|
$5.65 M
|
$5.39 M
|
| General & Administrative Expenses |
$17.74 M
|
$21.49 M
|
$22.78 M
|
$24.49 M
|
$24.31 M
|
$23.51 M
|
$22.76 M
|
$21.38 M
|
$18.58 M
|
$20.95 M
|
| Selling & Marketing Expenses |
$19.22 M
|
$22.21 M
|
$24.11 M
|
$25.04 M
|
$24.64 M
|
$19.92 M
|
$23.26 M
|
$24.44 M
|
$21.04 M
|
$20.49 M
|
| Selling, General & Administrative Expenses |
$36.96 M
|
$43.71 M
|
$46.89 M
|
$49.53 M
|
$48.95 M
|
$43.43 M
|
$46.02 M
|
$45.83 M
|
$39.61 M
|
$41.44 M
|
| Other Expenses |
$729.00 K
|
$6.87 M
|
$5.53 M
|
$5.89 M
|
$5.84 M
|
$5.71 M
|
$7.21 M
|
-$4.28 M
|
-$740.00 K
|
-$179.00 K
|
| Operating Expenses |
$46.51 M
|
$60.98 M
|
$64.18 M
|
$67.75 M
|
$65.59 M
|
$57.82 M
|
$63.95 M
|
$62.20 M
|
$47.70 M
|
$49.55 M
|
| Cost And Expenses |
$87.18 M
|
$100.35 M
|
$110.36 M
|
$120.27 M
|
$116.84 M
|
$101.88 M
|
$115.80 M
|
$119.79 M
|
$101.98 M
|
$105.66 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00 K
|
| Interest Expense |
$4.92 M
|
$3.21 M
|
$3.59 M
|
$2.55 M
|
$1.54 M
|
$4.83 M
|
$5.41 M
|
$5.37 M
|
$713.00 K
|
$642.00 K
|
| Depreciation & Amortization |
$5.95 M
|
$6.98 M
|
$7.00 M
|
$7.58 M
|
$7.62 M
|
$7.63 M
|
$7.73 M
|
$7.84 M
|
$2.91 M
|
$4.27 M
|
| EBITDA |
$5.32 M |
-$1.47 M |
$8.03 M |
$944.00 K |
$9.02 M |
$5.17 M |
$7.64 M |
$5.36 M |
-$101.00 K |
$1.80 M |
| EBITDA Ratio |
0.06
|
-0.02
|
0.07
|
0.01
|
0.08
|
0.05
|
0.07
|
0.04
|
-0
|
0.02
|
| Operating Income Ratio |
-0.01
|
-0.07
|
0.02
|
-0.06
|
0.02
|
0
|
0
|
0.01
|
-0
|
-0.03
|
| Total Other Income/Expenses Net |
-$56.76 M
|
-$5.45 M
|
-$4.45 M
|
-$2.25 M
|
-$2.21 M
|
-$7.51 M
|
-$5.88 M
|
-$8.96 M
|
-$1.99 M
|
-$81.00 K
|
| Income Before Tax |
-$57.39 M
|
-$11.67 M
|
-$2.56 M
|
-$9.18 M
|
-$140.00 K
|
-$7.29 M
|
-$5.50 M
|
-$8.52 M
|
-$2.09 M
|
-$3.08 M
|
| Income Before Tax Ratio |
-0.66
|
-0.12
|
-0.02
|
-0.08
|
-0
|
-0.07
|
-0.05
|
-0.07
|
-0.02
|
-0.03
|
| Income Tax Expense |
-$686.00 K
|
$740.00 K
|
$859.00 K
|
$337.00 K
|
$148.00 K
|
$518.00 K
|
-$815.00 K
|
-$3.68 M
|
-$1.22 M
|
$1.23 M
|
| Net Income |
-$56.70 M
|
-$12.41 M
|
-$3.42 M
|
-$9.52 M
|
-$288.00 K
|
-$7.81 M
|
-$4.69 M
|
-$3.46 M
|
-$865.00 K
|
-$4.31 M
|
| Net Income Ratio |
-0.66
|
-0.13
|
-0.03
|
-0.08
|
-0
|
-0.08
|
-0.04
|
-0.03
|
-0.01
|
-0.04
|
| EPS |
-12.8 |
-2.8 |
-0.805 |
-2.3 |
-0.071 |
-2 |
-1.2 |
-0.966 |
-0.257 |
-1.3 |
| EPS Diluted |
-12.8 |
-2.8 |
-0.805 |
-2.3 |
-0.071 |
-2 |
-1.2 |
-0.95 |
-0.249 |
-1.3 |
| Weighted Average Shares Out |
$4.44 M
|
$4.35 M
|
$4.24 M
|
$4.14 M
|
$4.03 M
|
$3.86 M
|
$3.78 M
|
$3.58 M
|
$3.36 M
|
$3.42 M
|
| Weighted Average Shares Out Diluted |
$4.44 M
|
$4.35 M
|
$4.24 M
|
$4.14 M
|
$4.03 M
|
$3.86 M
|
$3.78 M
|
$3.65 M
|
$3.48 M
|
$3.42 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
